208 related articles for article (PubMed ID: 14587047)
1. High-dose intravenous immunoglobulin treatment in two patients with acquired factor V inhibitors.
de Raucourt E; Barbier C; Sinda P; Dib M; Peltier JY; Ternisien C
Am J Hematol; 2003 Nov; 74(3):187-90. PubMed ID: 14587047
[TBL] [Abstract][Full Text] [Related]
2. Acquired coagulation factor inhibitors in children after topical bovine thrombin exposure.
Savage WJ; Kickler TS; Takemoto CM
Pediatr Blood Cancer; 2007 Dec; 49(7):1025-9. PubMed ID: 16526049
[TBL] [Abstract][Full Text] [Related]
3. Redo cardiac surgery: late bleeding complications from topical thrombin-induced factor V deficiency.
Cmolik BL; Spero JA; Magovern GJ; Clark RE
J Thorac Cardiovasc Surg; 1993 Feb; 105(2):222-7; discussion 227-8. PubMed ID: 8429648
[TBL] [Abstract][Full Text] [Related]
4. [A case positive for the inhibitor for coagulation factor V].
Nakagoshi R; Takamiya O; Nakata S; Ishikawa S; Higuchi Y; Okumura N; Ogiso Y
Rinsho Byori; 1999 Oct; 47(10):971-5. PubMed ID: 10590673
[TBL] [Abstract][Full Text] [Related]
5. Modulation of an acquired coagulation factor V inhibitor with intravenous immune globulin.
Tarantino MD; Ross MP; Daniels TM; Nichols WL
J Pediatr Hematol Oncol; 1997; 19(3):226-31. PubMed ID: 9201145
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment with rituximab in a patient with an acquired factor V inhibitor.
Lebrun A; Leroy-Matheron C; Arlet JB; Bartolucci P; Michel M
Am J Hematol; 2008 Feb; 83(2):163-4. PubMed ID: 17849464
[TBL] [Abstract][Full Text] [Related]
7. Acquired inhibitors of factor V.
Feinstein DI
Thromb Haemost; 1978 Jun; 39(3):663-74. PubMed ID: 705695
[TBL] [Abstract][Full Text] [Related]
8. [Clinical cases of acquired coagulation inhibitors].
Yamane T; Hino M; Ota K; Akahori M; Hirai M; Inoue T; Mugitani A; Tatsumi N
Rinsho Byori; 2000 Dec; 48(12):1093-101. PubMed ID: 11215417
[TBL] [Abstract][Full Text] [Related]
9. [High-titer idiopathic acquired factor V inhibitor patient showing decreased activities of multiple coagulation factors].
Shimizu I; Ichikawa N; Yotsumoto M; Sumi M; Ueno M; Kobayashi H
Rinsho Ketsueki; 2008 Jun; 49(6):413-6. PubMed ID: 18646609
[TBL] [Abstract][Full Text] [Related]
10. Bovine thrombin induces an acquired coagulopathy in sensitized patients undergoing revision spinal surgery: a report of two cases.
Poynton AR; Nelson MC; McCance SE; Levine RL; O'Leary PF
Spine (Phila Pa 1976); 2003 Jun; 28(12):E221-3. PubMed ID: 12811284
[TBL] [Abstract][Full Text] [Related]
11. Development of antibodies to human thrombin and factor V in a pediatric patient exposed to topical bovine thrombin.
Lo CY; Jones C; Glader B; Zehnder JL
Pediatr Blood Cancer; 2010 Dec; 55(6):1195-7. PubMed ID: 20979176
[TBL] [Abstract][Full Text] [Related]
12. [Acquired factor V deficiency: a rare bleeding disorder with variable clinical presentations].
Alcantara M; Ducastelle S; Rugeri L; Dargaud Y
Rev Med Interne; 2011 May; 32(5):e59-61. PubMed ID: 20638758
[TBL] [Abstract][Full Text] [Related]
13. [A long-lasting idiopathic factor V inhibitor].
Okoshi Y; Akiyama H; Inoue T; Koyama T; Kono N; Matsumura T; Mizuchi D; Mori S; Ohashi K; Sakamaki H
Rinsho Ketsueki; 2003 Jan; 44(1):14-8. PubMed ID: 12649832
[TBL] [Abstract][Full Text] [Related]
14. Clinical and laboratory diagnosis of autoimmune factor V inhibitors: A single institutional experience.
Sridharan M; Fylling KA; Ashrani AA; Chen D; Marshall AL; Hook CC; Cardel LK; Nichols WL; Pruthi RK
Thromb Res; 2018 Nov; 171():14-21. PubMed ID: 30227314
[TBL] [Abstract][Full Text] [Related]
15. Advances in understanding the bleeding diathesis in factor V deficiency.
Duckers C; Simioni P; Rosing J; Castoldi E
Br J Haematol; 2009 Jun; 146(1):17-26. PubMed ID: 19438479
[TBL] [Abstract][Full Text] [Related]
16. High-titer acquired factor V inhibitor responsive to corticosteroids and cyclophosphamide in a patient with two malignant tumors.
Bayani N; Rugina M; Haddad-Vergnes L; Lelong F
Am J Hematol; 2002 Sep; 71(1):33-6. PubMed ID: 12221671
[TBL] [Abstract][Full Text] [Related]
17. Immunization by bovine thrombin used with fibrin glue during cardiovascular operations. Development of thrombin and factor V inhibitors.
Berruyer M; Amiral J; Ffrench P; Belleville J; Bastien O; Clerc J; Kassir A; Estanove S; Dechavanne M
J Thorac Cardiovasc Surg; 1993 May; 105(5):892-7. PubMed ID: 8487567
[TBL] [Abstract][Full Text] [Related]
18. Spectrum of bleeding in acquired factor V inhibitor: a summary of 33 cases.
Wiwanitkit V
Clin Appl Thromb Hemost; 2006 Oct; 12(4):485-8. PubMed ID: 17000894
[TBL] [Abstract][Full Text] [Related]
19. [Hereditary factor V deficiency and factor V inhibitor without bleeding. Rare causes of pathological screening tests of coagulation].
Borucki K; Töpfer G; Hartung KJ; Lutze G
Hamostaseologie; 2007 Aug; 27(3):188-90. PubMed ID: 17694226
[TBL] [Abstract][Full Text] [Related]
20. Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy.
Field JJ; Fenske TS; Blinder MA
Haemophilia; 2007 Jan; 13(1):46-50. PubMed ID: 17212724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
